Incomplete Freund's Adjuvant
Incomplete Freund's Adjuvant - Related Videos
04:13
An Adjuvant Therapy in a Mouse Model with an Incompletely Resected Subcutaneous Tumor
0 Views •
2025
This video illustrates testing of adjuvant or additional therapy in a mouse model with incompletely resected subcutaneous tumors. The partially tumor-resected mouse is treated with an antibody targeting the anti-cytotoxic protein of T regulatory cells, potentially reducing tumor regrowth and suggesting effective adjuvant therapy.
03:29
A Technique to Generate an Adjuvant-Induced Arthritis Mouse Model
0 Views •
2025
This video demonstrates a method to generate adjuvant-induced arthritis in a murine model. Complete Freund's adjuvant (CFA) is injected in the mouse ankle joint and periarticular areas. CFA activates the immune system, leading to neutrophil infiltration and exaggerated inflammation.
01:50
Preparation of a Nanoemulsion Adjuvant Vaccine
0 Views •
2025
This video demonstrates the production of nanoemulsion tumor vaccines. The stable oil reservoir depots carrying synthetic peptides and adjuvants are produced by low-energy nanoemulsion, offering significant promise for tumor immunotherapy.
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
0 Views •
Cited by 7 •
2020
In this protocol, we describe a mouse model of incomplete surgical resection of soft tissue sarcoma for testing (neo)adjuvant therapies.
01:43
Incomplete Dominance
0 Views •
2021
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism. According to Mendel, organisms with both copies or a single copy of the dominant allele display a...
FAQs
The water-in-oil emulsion retains antigen at the injection site, creating a depot that slows its release. This prolonged local presence is accompanied by inflammatory signals and recruitment of immune cells, which can increase the opportunity for antigen-specific immune activation. In experimental immunization, the depot therefore affects both antigen availability over time and the local tissue environment.
IFA lacks the mycobacterial components found in Complete Freund's Adjuvant, so the two formulations are not interchangeable in experimental design. This distinction helps investigators study responses enhanced by the oil-emulsion formulation without introducing that additional component set. It is especially relevant when comparing adjuvant conditions or interpreting how formulation choices shape antigen-specific immune responses.
Injection history and administration quality can influence both experimental tolerability and interpretation. Repeated or improperly administered injections may produce local tissue reactions at the injection site. Consequently, researchers must treat injection conditions as an important experimental consideration, because visible local effects can complicate assessment of immune responses attributed to the antigen-adjuvant formulation.
An experimental immunization pairs IFA with a co-administered antigen and delivers the formulation by injection. Afterward, investigators assess antigen-specific immune responses, including antibody and cellular responses, in relation to the study question. This workflow allows the formulation to be examined as part of studies of pathogen antigens, vaccine candidates, or mechanisms of immunity.
IFA supports experimental immunization studies that examine pathogen antigens, vaccine candidates, and immune mechanisms. In these settings, investigators can use it to strengthen antigen-specific antibody or cellular responses so that responses to a candidate antigen can be evaluated. Its value is therefore comparative and investigative, helping assess how immune responses change under a defined adjuvant condition.
Results should be interpreted as antigen-specific immune effects within the selected formulation and immunization design. IFA can support evaluation of both antibody and cellular responses, but local tissue reactions from repeated or improper injections may also occur. Recording those reactions is important because they provide context for judging experimental outcomes and distinguishing intended immune readouts from administration-related effects.